SEONGNAM, South Korea, April 6, 2025 /PRNewswire/ -- ABL Bio Inc. (KOSDAQ: 298380), a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and neurodegenerative ...

Brain Bio-Digital Twin technology has the potential to change medical treatment practices by eliminating the need for invasive and costly testing, preventing medical errors and accelerating clinical ...

For the first time, scientists can now leverage the reproducibility of ioCells to study how the four major CNS cell types interact and contribute to neurological diseases. This enables more precise ...

Exvade Bioscience™, a clinical-stage neuro-oncology company advancing a breakthrough platform for treating aggressive brain cancers, today highlighted ongoing enrollment in a Phase 1 clinical trial ...

Cyber-punked: A functional blend of biology and microchips for novel bio-computing applications is yet to materialize outside science fiction stories. Thanks to 'Brainoware,' scientists believe they ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I analyze the recently announced ...

Scientific Longevity Company Collaborates with Major Academic Institutions to Remove Tumor Defense Mechanisms and Help Defeat Cancer in a Non-Toxic Manner MIAMI, Dec. 4, 2025 /PRNewswire/ -- Immorta ...

Mustang Bio, a clinical-stage biopharmaceutical company headquartered in Worcester, has received clearance from the U.S. Food and Drug Administration to enter into clinical trials for a drug to treat ...

JuneBrain Inc., a Baltimore-based neurotech startup, took first place at the 2025 BioChallenge Pitch Competition, held October 30 at the New Orleans BioInnovation Center (NOBIC). The annual contest ...

What just happened? Imperial College London researcher Ildar Rakhmatulin is asking for money to manufacture a cheap, accessible and multi-purpose brain-computer "interface." Rather than drilling a ...